Market close
Swedish equities ended the trading day higher on Tuesday, with the OMX Stockholm 30 index climbing 0.27% by the close in Stockholm. Strength in Healthcare, Telecoms and Financials underpinned the session's gains.
Top and bottom movers
The strongest performers on the OMX Stockholm 30 were AstraZeneca PLC (ST:AZN), Skanska AB ser. B (ST:SKAb) and Evolution AB (ST:EVOG). AstraZeneca led the list with a 2.64% advance, up 48.50 points to finish at 1,886.00. Skanska B added 1.85%, gaining 4.90 points to close at 269.40, while Evolution rose 1.65%, or 8.60 points, to end the session at 528.80.
On the downside, Boliden AB (ST:BOL) was the weakest member of the index, slipping 2.78% or 18.00 points to 628.40 at the close. Epiroc AB Class A (ST:EPIRa) declined 1.16%, losing 3.00 points to 255.80, and Sandvik AB (ST:SAND) fell 1.11%, down 4.20 points to 372.90.
Breadth and listing activity
Declining issues outnumbered advancing ones on the Stockholm exchange by 402 to 322, with a further 77 shares finishing unchanged.
Notable high
Shares of AstraZeneca PLC (ST:AZN) reached an all time high in the session, marking a 2.64% rise, or 48.50 points, to 1,886.00 at the close.
Commodities
In commodities, crude oil for April delivery fell 1.23%, down 0.77 to $61.98 a barrel. Brent oil for April delivery lost 2.33%, sliding 1.60 to $67.05 a barrel. April Gold Futures registered a 3.22% decline, off 162.51 to trade at $4,883.79 a troy ounce.
Foreign exchange and dollar index
Currency moves showed the euro stronger against the krona, with EUR/SEK up 0.62% to 10.65. USD/SEK also rose, increasing 0.73% to 9.00. The US Dollar Index Futures was firmer, up 0.38% at 97.19.
Market context
Overall, the session closed with modest gains for the main Swedish benchmark, supported by outperformance in healthcare, telecoms and financial stocks, even as commodity prices and a firmer dollar weighed on some sectors.